Global Health Ltd

NSE: MEDANTA · BSE: 543654 · Healthcare · 37 announcements

Share price: ₹1,294.10
Market cap: ₹34,795 Cr
Revenue (annual): ₹4,410 Cr
Net profit (annual): ₹556.5 Cr
P/E (TTM): 62.6×Sector 53.1×
Promoter holding: 33.00%-0.01% QoQ
FII holding: 9.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 9 Earnings Call 6 Other Announcement 3 Financial Results 3 Annual General Meeting 3 Acquisition 3 Results Update 2 Management Change 2 Capacity Expansion 2 Board Meeting Date 2 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

27 Apr 2026 15:09 IST NSE

Acquisition

Global Health Acquisition Worth ₹30 Cr

Global Health Limited (Medanta) entered a Business Transfer Agreement to acquire an 80-bed Cancer Hospital in Indore for ₹30 Crore. The facility, located near Medanta's existing Indore hospital, adds comprehensive oncology services and strengthens its Central India presence. The transaction includes the assignment of a long-term lease.

Value: ₹30.00 Cr

Read the filing ↗

27 Apr 2026 14:44 IST NSE

Acquisition

Global Health Acquisition Worth ₹30 Cr

Global Health Limited (Medanta) approved the acquisition of a 79-bedded cancer care hospital in Indore for ₹30 Crore. The facility, currently operated by AIOPL, will be integrated into the Medanta network by September 2026. This strategic expansion strengthens Medanta's oncology presence and regional footprint in close proximity to its existing Indore facility.

Value: ₹30.00 Cr
Execution: September 30, 2026 (Long stop date)

Read the filing ↗

27 Apr 2026 14:51 IST NSE

Acquisition

Global Health Acquisition Worth ₹30 Cr

Global Health Limited (Medanta) has agreed to acquire a 79-bedded cancer care hospital in Indore from AIOPL for ₹30 Crore. The transaction, expected to close by September 30, 2026, expands Medanta's healthcare network into the Indore market. The acquisition is subject to customary statutory approvals.

Value: ₹30.00 Cr
Execution: Expected completion by 30-09-2026

Read the filing ↗